Concepedia

Ayako Ojima

AO

16

Publications

882

Citations

16

H-Index

1986

Active since

Affiliations

Kurume University(Current)

Kanazawa Medical University

Kurume University Medical Center

Teikyo University

Ayako Ojima is an author at Kurume University specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1986–2016

16

Publications

16

Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis

Ayako Ojima, Takanori Matsui, Yoshinori Nishino et al. · Hormone and Metabolic Research · 2015 · 212 citations · Full text

Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression

Ayako Ojima, Yuji Ishibashi, Takanori Matsui et al. · American Journal Of Pathology · 2012 · 153 citations · Full text

, , +10

Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta

Takanori Matsui, Nobutaka Nakamura, Ayako Ojima et al. · Nutrition Metabolism and Cardiovascular Diseases · 2016 · 70 citations

, , +12

Glucose-dependent Insulinotropic Polypeptide (GIP) Inhibits Signaling Pathways of Advanced Glycation End Products (AGEs) in Endothelial Cells via its Antioxidative Properties

Ayako Ojima, Takanori Matsui, Sayaka Maeda et al. · Hormone and Metabolic Research · 2012 · 58 citations

Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis

Takanori Matsui, Sae Nakashima, Yuri Nishino et al. · Laboratory Investigation · 2015 · 52 citations · Full text

, , +7

Rows per page

1–5 of 16